Portal de Oportunidades de Pesquisa – POP – Propesq

Objetivo:
The Funding Opportunity Announcement (FOA) encourages the submission of investigator-initiated research grant applications to support the secondary analysis of existing data sets with the goal of enhancing our understanding of patterns of alcohol consumption, the epidemiology and etiology, including genetics, of alcohol-related problems. Research grants for the Secondary Analyses of Existing Alcohol Research Data are intended to provide support for studies that utilize currently available data sets to increase our understanding of the incidence, prevalence and etiology of alcohol related problems and disorders in the population, as well as the risk and protective factors associated with them.

Inscrições:
R01: October 05, 2017;
R03: October 16, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
September 8, 2020.

Mais informações em R01 e R03.

Objetivo:
The purpose of the Funding Opportunity Announcement (FOA) is to support the development of chemical probes that aid basic research investigations on substance use disorders (SUDs) or identify new lead chemical scaffolds with potential for structure activity relationship (SAR) studies on SUDs. In the long term, it is hoped that these lead chemical scaffolds will provide a greater number of pharmacological tools for basic research and possible drug candidates for medications development.

Inscrições:
R21/R33: October 16, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
September 8, 2019.

Mais informações no site.

Objetivo:
The overall goal of this funding opportunity announcement (FOA) is to encourage the submission of research grant applications to investigate the molecular mechanisms by which oncogenic fusion genes and their gene products contribute to pediatric sarcoma initiation, progression, and metastasis. Better understanding of the molecular pathways activated by chromosomal translocations in pediatric sarcomas, and their relationship to oncogenesis and tumor progression, can elucidate mechanisms of cancer pathogenesis and potentially lead to novel therapeutics.

Inscrições:
R01: October 05, 2017;
R21: October 16, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
May 8, 2020.

Mais informações em R01 e R21.

Objetivo:
The Funding Opportunity Announcement (FOA) invites research grant applications from organizations/institutions that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies.

Inscrições:
R01: October 05, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
September 8, 2019.

Mais informações no site.

Objetivo:
The Funding Opportunity Announcement (FOA) invites research grant applications studying mechanisms of HIV-1 persistence and eradication strategies specifically focused on the central nervous system (CNS) in the context of viral suppression. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required.

Inscrições:
R01: October 05, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
January 8, 2020.

Mais informações no site.

Objetivo:
The purpose of the Funding Opportunity Announcement (FOA) is to encourage research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to Autism Spectrum Disorders (ASD).

Inscrições:
R01: October 05, 2017;
R03 and R21: October 16, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
September 8, 2019.

Mais informações em R01, R03 e R21.

Evento:
CBIE – Congresso Brasileiro de Informática da Educação: Aprendizagem das Coisas.

Data:
de 30 de outubro a 02 de novembro de 2017.

Inscrições:
até 02 de novembro de 2017.

Local:
Recife, Brasil.

Mais informações no site.

Objetivo:
Data from clinical studies of metformin in a variety of patient populations suggest that it may have other effects, besides being an antihyperglycemic agent, which warrant further attention in translational aging research. The objective of the Funding Opportunity Announcement (FOA) is to support research projects (R01), including small-scale physiologic studies in humans or secondary analyses of data and/or stored biospecimens from controlled clinical intervention studies, to increase the understanding of the clinical translational potential of metformin to delay deleterious aging changes or to extend healthy human life span. This includes identification of specific populations particularly likely to benefit from treatment, and/or obtaining information on metformins human physiologic and cellular effects that would be useful in identifying novel molecular targets.

Inscrições:
R01: October 05, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
May 8, 2020.

Mais informações no site.

Objetivo:
The Funding Opportunity Announcement (FOA) encourages research grant applications directed toward developing next-generation human cell-derived microphysiological systems (MPS) with improved fidelity to complex human brain, spinal, peripheral nervous system and/or sensory end organ circuit physiology in vivo, which will ultimately facilitate analysis of higher order functional deficits relevant to complex nervous system disorders.

Inscrições:
R01: October 05, 2017;
R21: October 16, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
January 8, 2020.

Mais informações em R01, R21.

Objetivo:
The National Library of Medicine (NLM) offers support for innovative research in biomedical informatics and data science. The scope of NLM s interest in the research domain of informatics is broad and interdisciplinary, developing methods and approaches in biomedical computing, data science and related information fields for application domains of health and biomedicine, including health care delivery, basic biomedical research, clinical and translational research, precision medicine, public health, biosurveillance, health information management in disasters, and similar areas. NLM defines biomedical informatics as the science of optimal representation, organization, management, integration and presentation of information relevant to human health and biology, for purposes of learning, sharing and use.

Inscrições:
R01: October 05, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
September 8, 2019.

Mais informações no site.